About: Integrating harm reduction and clinical care: Lessons from Covid-19 respite and recuperation facilities

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Integrating harm reduction and clinical care: Lessons from Covid-19 respite and recuperation facilities Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Integrating harm reduction and clinical care: Lessons from Covid-19 respite and recuperation facilities
Creator	Ma, M Barocas, Joshua Bazzi, Angela Kimmel, Simeon
Source	Elsevier; PMC
abstract	Abstract In response to the novel coronavirus 2019 (Covid-19) pandemic, many people experiencing homelessness and substance use disorders entered respite and recuperation facilities for care and to isolate and prevent subsequent SARS-CoV-2 transmission. However, because drug use was officially prohibited in these facilities, we observed people who use substances leaving isolation temporarily or prematurely. The initial Covid-19 surge magnified the need for harm reduction access for those who use substances to ensure their safety and well-being and that of their local communities. In this commentary, we argue that expanding harm reduction access is crucial for subsequent waves of SARS-CoV-2 infection and also for patients who use substances and are hospitalized for other reasons.
has issue date	2020-08-12(xsd:dateTime)
bibo:doi	10.1016/j.jsat.2020.108103
has license	els-covid
sha1sum (hex)	5b06bb130623a68d1f7d17fd6267c426908e1f17
schema:url	https://doi.org/10.1016/j.jsat.2020.108103
resource representing a document's title	Integrating harm reduction and clinical care: Lessons from Covid-19 respite and recuperation facilities
has PubMed Central identifier	PMC7419278
schema:publication	J Subst Abuse Treat
resource representing a document's body	covid:5b06bb130623a68d1f7d17fd6267c426908e1f17#body_text
is schema:about of	named entity 'Covid-19' named entity 'skilled nursing facilities' named entity 'Public Health' named entity 'Journal' named entity 'respite' named entity 'JAB' named entity 'IMPROVE ACCESS' named entity 'BARRIER' named entity 'INTERESTS' named entity 'HARM REDUCTION' named entity 'DECLARATION' named entity 'respite' named entity 'integrated' named entity 'medications' named entity 'isolation' named entity 'Associates' named entity 'Covid-19 pandemic' named entity 'Covid' named entity 'skilled nursing facilities' named entity 'Harm reduction' named entity 'Harm reduction' named entity 'coronavirus 2' named entity 'health and safety' named entity 'United States' named entity 'Canada' named entity 'SARS-CoV-2' named entity 'abstinence' named entity 'SARS-CoV-2' named entity 'Covid' named entity 'NIDA' named entity 'fatal overdose' named entity 'tested positive' named entity 'harm reduction' named entity 'overdose' named entity 'harm reduction' named entity 'overdose' named entity 'National Institute on Drug Abuse' named entity 'harm reduction' named entity 'OPS' named entity 'SARS-CoV-2' named entity 'evidence-based' named entity 'Overdose Prevention' named entity 'Boston Medical Center' named entity 'methadone' named entity 'Harm reduction' named entity 'infection' named entity 'clinical care' named entity 'syringe service' named entity 'overdose' named entity 'Covid' named entity 'United States' named entity 'homelessness' named entity 'unable to access' named entity 'syndromic surveillance' named entity 'Harm reduction' named entity 'homelessness' named entity 'opioids' named entity 'clinical care' named entity 'chronic medical condition' named entity 'harm reduction' named entity 'health services' named entity 'Covid-19 pandemic' named entity 'substance use disorders' named entity 'NIDA' named entity 'Gaeta' named entity 'expanded access' named entity 'policy-makers' named entity 'Covid' named entity 'evidence-based' named entity 'Covid' named entity 'overdose' named entity 'buprenorphine' named entity 'SARS-CoV-2' named entity 'abstinence' named entity 'harm reduction' named entity 'Harm reduction' named entity 'clinical care' named entity 'Massachusetts' named entity 'U.S.' named entity 'naloxone'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software